Chengwei Wang

Dr. Chengwei Wang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2020 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Open access
PDF file
XWXiaoyu Wang
Xiaoyu Wang
JLJunyi Li
Junyi Li
CWChengwei Wang
Chengwei Wang
JLJianqin Lv
Jianqin Lv
Objective: Spontaneous intracerebral hemorrhage (sICH) is a devastating disease that can lead to poststroke depression (PSD) and greatest impact on the quality of life (QOL) of patients. Mindfulness meditation was viewed as one of the effective ways to reduce PSD in patients with cancer. The present study tried to investigate whether mindfulness meditation has potential benefits in PSD and QOL for sICH patients in China.Methods: Two hundred and two patients in West China Hospital, Sichuan University, enrolled from January 2017 to December 2018 were included in a randomized controlled trial. After removing missing values, there were 67 in control group and 67 in intervention group. Patients in intervention group received 2‐month mindfulness‐based cognitive therapy, and patients in control group received stress management education (ie, an active control).Results: The results suggested that the significant differences of depression, trait mindfulness, social well‐being, emotional well‐being, and total score of QOL were found in intervention group from time 1 to time 2. Physical well‐being and the score of NIH stroke scale experienced significant changes in both control group and intervention group over time.Conclusions: Mindfulness‐based intervention has positive effects on sICH patients' depression, social well‐being, and emotional well‐being. However, the change of trait mindfulness over time could not explain these positive effects. Future studies could explore the mechanism of mindfulness‐based intervention on sICH patients' depression and QOL and clarify the boundaries of the positive effects of mindfulness‐based intervention.

24 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MAMunire Abudurexiti
Munire Abudurexiti
YZYue Zhao
Yue Zhao
XWXiao-ling Wang
Xiao-ling Wang
LHLu Han
Lu Han
TLTianqing Liu
Tianqing Liu
ZYZhi-xiang Yuan
Zhi-xiang Yuan
With their seemingly limitless capacity for self-improvement, stem cells have a wide range of potential uses in the medical field. Stem-cell-secreted extracellular vesicles (EVs), as paracrine components of stem cells, are natural nanoscale particles that transport a variety of biological molecules and facilitate cell-to-cell communication which have been also widely used for targeted drug delivery. These nanocarriers exhibit inherent advantages, such as strong cell or tissue targeting and low immunogenicity, which synthetic nanocarriers lack. However, despite the tremendous therapeutic potential of stem cells and EVs, their further clinical application is still limited by low yield and a lack of standardized isolation and purification protocols. In recent years, inspired by the concept of biomimetics, a new approach to biomimetic nanocarriers for drug delivery has been developed through combining nanotechnology and bioengineering. This article reviews the application of biomimetic nanocarriers derived from stem cells and their EVs in targeted drug delivery and discusses their advantages and challenges in order to stimulate future research.

25 August 2018 in Brain Imaging and Behavior
Verified
Journal Article
Closed access
HYHong Yang
Hong Yang
CWChengwei Wang
Chengwei Wang
GJGongjun Ji
Gongjun Ji
ZFZhan Feng
Zhan Feng
JDJingfeng Duan
Jingfeng Duan
HXHaiyan Xie
Haiyan Xie

23 June 2020 in Biochemistry and Molecular Biology Education
Verified
Journal Article
Closed access
PDF file
XWXiaoyu Wang
Xiaoyu Wang
JLJunyi Li
Junyi Li
CWChengwei Wang
Chengwei Wang

11 June 2015 in Chinese Journal of Integrative Medicine
Verified
Journal Article
Closed access
PDF file
QXQi-Ming Xue
Qi-Ming Xue
NLNing Li
Ning Li
ZLZhishun Liu
Zhishun Liu
CWChengwei Wang
Chengwei Wang
JLJianqin Lu
Jianqin Lu

28 November 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
JLJian-Qin Lv
Jian-Qin Lv
CWChengwei Wang
Chengwei Wang
YYYi Yang
Yi Yang
YLYu Li
Yu Li
TXTian-Hao Xu
Tian-Hao Xu
LJLing-Qi Jian
Ling-Qi Jian
Introduction Postoperative nausea and vomiting (PONV) is among the most common adverse reactions following anaesthesia and surgery. Recent clinical studies have reported that the average incidence is about 30%, while in patients specifically undergoing neurosurgery, the incidence can be as great as 73%. Studies also suggest that its occurrence increases the risk of intracranial haematoma and haemorrhage. The objective of this study is to evaluate the effectiveness of intradermal thumbtack needle buried Neiguan (pericardium 6 (P6)) point therapy in the prevention of PONV in patients undergoing craniotomy under general anaesthesia. Methods and analysis This is a single-centre, three-arm, randomised controlled trial. 180 participants are randomly assigned to either an acupuncture, intradermal thumbtack needle or control group in a 1:1:1 ratio. The P6 of the acupuncture group is punctured at both sides perpendicularly to a depth of 20 mm. Needles are retained for 30 min and stimulated every 10 min to maintain the de qi. The therapy includes two treatments; the acupuncture is administered immediately after and 24 hours after surgery. For the intradermal thumbtack needle group, the intradermal thumbtack needle is quickly inserted into the skin and embedded at P6 acupoints bilaterally. Patients and their families are asked to press the needlepoint with the onset of nausea, vomiting, bloating, pain and other reported discomforts. The needle is replaced after 24 hours. The therapy is administered immediately after and 24 hours after surgery. For the control group, no intervention is carried out. The incidence of PONV within 48 hours after craniotomy across the three groups is observed. Other observations include: (1) assessment of nausea score (severity of nausea) and pain score (visual analogue scale) 0–2, 2–6, 6–24 and 24–48 hours after craniotomy under general anaesthesia; (2) assessment of total rescue antiemetic dosage 0–48 hours after craniotomy under general anaesthesia; (3) length of hospital stay and (4) patient satisfaction score with PONV management. We will perform all statistical analysis following the intention-to-treat principle. Ethics and dissemination Ethics approval has been granted by the Bioethics Subcommittee of the West China Hospital, Sichuan University: the approval number is 2018 (number 231). Results will be expected to be published in peer-reviewed journals. Trial registration number ChiCTR1800017173